https://www.selleckchem.com/products/Nolvadex.html
Background The prevalence and predictors of left atrial appendage thrombus (LAAT) in patients with non-valvular atrial fibrillation (AF) who have been treated with non-vitamin K antagonist oral anticoagulants (NOACs) are not well defined. We aimed to assess the occurrence and predictors of LAAT on transesophageal echocardiography (TOE) in patients with non-valvular AF treated with NOACs for at least 3 weeks. Methods Consecutive patients with non-valvular AF who underwent TOE before catheter ablation or electrical cardioversion in three
Gefällt mir
Kommentar
Teilen
